Fidelity Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $904K | Buy |
|
|||||
|
2023
Q2 | $488K | Buy |
|
|||||
|
2023
Q1 | $591K | Sell |
|
|||||
|
2022
Q4 | $547K | Sell |
|
|||||
|
2022
Q3 | $13M | Sell |
|
|||||
|
2022
Q2 | $28.5M | Sell |
|
|||||
|
2022
Q1 | $38M | Sell |
|
|||||
|
2021
Q4 | $40.4M | Sell |
|
|||||
|
2021
Q3 | $38.1M | Sell |
|
|||||
|
2021
Q2 | $51.5M | Sell |
|
|||||
|
2021
Q1 | $66.2M | Sell |
|
|||||
|
2020
Q4 | $86.4M | Sell |
|
|||||
|
2020
Q3 | $155M | Sell |
|
|||||
|
2020
Q2 | $231M | Sell |
|
|||||
|
2020
Q1 | $307M | Buy |
|
|||||
|
2019
Q4 | $602M | Buy |
|
|||||
|
2019
Q3 | $322M | Buy |
|
|||||
|
2019
Q2 | $386M | Buy |
|
|||||
|
2019
Q1 | $498M | Buy |
|
|||||
|
2018
Q4 | $448M | Buy |
|
|||||
|
2018
Q3 | $560M | Sell |
|
|||||
|
2018
Q2 | $372M | Buy |
|
|||||
|
2018
Q1 | $232M | Buy |
|
|||||
|
2017
Q4 | $220M | Buy |
|
|||||
|
2017
Q3 | $218M | Buy |
|
|||||
|
2017
Q2 | $454M | Buy |
|
|||||
|
2017
Q1 | $421M | Buy |
|
|||||
|
2016
Q4 | $404M | Buy |
|
|||||
|
2016
Q3 | $610M | Buy |
|
|||||
|
2016
Q2 | $526M | Buy |
|
|||||
|
2016
Q1 | $470M | Buy |
|
|||||
|
2015
Q4 | $545M | Buy |
|
|||||
|
2015
Q3 | $602M | Buy |
|
|||||
|
2015
Q2 | $872M | Buy |
|
|||||
|
2015
Q1 | $1.01B | Buy |
|
|||||
|
2014
Q4 | $500M | Buy |
|
|||||
|
2014
Q3 | $753M | Buy |
|
|||||
|
2014
Q2 | $751M | Buy |
|
|||||
|
2014
Q1 | $953M | Buy |
|
|||||
|
2013
Q4 | $182M | Buy |
|
|||||
|
2013
Q3 | $163M | Buy |
|
|||||
|
2013
Q2 | $89.7M | Buy |
|